期刊文献+

5α-雄甾-2-烯-17-酮的合成工艺研究

Synthesis of 5α-Androst-2-en-17-one
下载PDF
导出
摘要 以表雄酮为原料,采用固体酸催化剂,一步脱水合成肌肉松弛药的中间体5α-雄甾-2-烯-17-酮。通过对反应温度、催化剂和表雄酮的配比及催化剂的酸度进行优化,得出优化工艺条件:反应温度105℃,m(催化剂)∶m(表雄酮)=5∶1,催化剂酸度为4.5%,反应时间2 h,收率87.1%。 5α-Androst-2-en-17-one which is an intermediate of muscle relaxants was synthesized from commercially available epiandrosterone catalyzed by silica supported sulfuric acid.Influences of the reaction temperature,the ratio of m(catalyst)∶m(epiandrosterone) and the acidity of the catalyst were investigated.The optimum reaction conditions were obtained as follows: reaction temperature 105℃,m(catalyst)∶m(epiandrosterone)ratio 5:1,catalyst acidity 4.5%,reaction time 120 min.The product was resulted in 87.1% yield.
出处 《精细化工中间体》 CAS 2011年第6期34-36,共3页 Fine Chemical Intermediates
关键词 固体酸催化剂 表雄酮 5α-雄甾-2-烯-17-酮 合成 solid acid catalyst epiandrosterone 5α-androst-2-en-17-one synthesis
  • 相关文献

参考文献13

  • 1薛富善,孙伯华,邹勤,罗来葵.泮库溴铵在小儿药代动力学的研究[J].中华麻醉学杂志,1996,16(6):259-262. 被引量:2
  • 2王玉成,陈玉芳,李磊,赵士魁.维库溴铵的合成[J].中国药物化学杂志,2006,16(4):233-235. 被引量:15
  • 3张永明,郭佳,熊涛,赵滟萍,丁聪,李宗桃.罗库溴铵的合成研究[J].中国药物化学杂志,2008,18(6):434-438. 被引量:9
  • 4庄心良,屈桂莲,王莹恬,王珍娣.哌库溴铵的临床应用[J].中华麻醉学杂志,1996,16(3):119-120. 被引量:2
  • 5李志达 郭文璟 何长云等.环硫雄醇的改进合成.有机化学,1986,(5):394-394.
  • 6Marker R E, Kamm O. Sterols. XIV [J]. Pyroandrosterone and Derivatives. Journal of the American Chemical Society, 1937, 59 (7) : 1 363-1 366.
  • 7Hochschschule T. Steroids and sex hormones. CXIII. Relationship between the constitution andodor of steroids [J ]. Helvetica Chimica Acta, 1945, 28: 618-637.
  • 8Arte J G. Rosenkranzl, Steroids LXV.1 A Synthesis of androsterone [J]. The Journal of Organic Chemistry, 1955, 20 (4) : 542-545.
  • 9Magni A. Process for preparing neuromuscular blocking agents and intermediates useful: US, 5808051[P]. 1998-09-15.
  • 10Crabbe P, Leon C. Novel dehydration reaction of steroidal alcohols [J]. The Journal of Organic Chemistry1970 35 (8) : 2 594-2 596.

二级参考文献18

  • 1裴凌,盛卓人.罗库溴铵欧洲研讨会综述[J].国外医学(麻醉学与复苏分册),1995,16(4):219-222. 被引量:18
  • 2ALEX Z. Methods of treating involuntary facial wrinkes: US, 2004/037895[P]. 2004 - 02 - 26.
  • 3TUBA Z, MARSAI M. Acylated diepoxy-androstane and a process for the preparation thereof: US, 4110326[P] . 1978 - 08 - 29.
  • 4THOMAS S, DVID S, IAN C. Novel 2β-morpholinoandrostane derivatives: US, 4894369 [ P]. 1990 - 01 - 16.
  • 5MENDEZ J, DELA M, RODRIGUEZ A, et al. Process for the synthesis of rocuronium bromide: WO, 2007/033348[P]. 2007 - 03 - 22.
  • 6AMBROGIO M, PARIDE G. Process for preparing neuromuscular blocking agents and intermediates use- ful therefor: US, 6090957[P]. 2000 - 07 - 18.
  • 7AMBROGIO M, PARIDE G. Process for preparing neuromuscular blocking agents and intermediates use- ful therefor: US, 5817803[P], 1998 - 10 - 06.
  • 8AMBROGIO M. PARIDE G. Process for preparing neuromuscular blocking agents and intermediates use- ful therefor: US, 5808051 [ P], 1998 - 09 - 27.
  • 9ELIEZER A, DAVID S, ODED F, et al. Processes for the preparation of rocuronium bromide and intermediates thereof: US, 2005/0159398[ P]. 2005 - 07 - 21.
  • 10ZOLTAN T, MARIA B. 2, 16-Dipiperazinyl steroids: GB, 1398050[P]. 1975 - 06 - 18.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部